Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Virtual Booth

Contact Supplier

Rusan Pharma: Over 30 years of specializing in the treatment of Addiction and Pain Management.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

DEVELOPMENTS

3 Drugs in Development

3 Drugs in Development

DIGITAL CONTENT

1 NEWS #PharmaBuzz

media
1 NEWS #PharmaBuzz

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

3DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Finished Drug Prices

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: Luvadaxistat [usan], Tak-831, 76ic00yrvr, Tak831, Chembl2338801, 4-hydroxy-6-{2-[4-(trifluoromethyl)phenyl]ethyl}pyridazin-3(2h)-one

Molecular Formula

C₁₃H₁₁F₃N₂O₂

Molecular Weight

284.23 g/mol

InChI Key

QBQMUMMSYHUDFM-UHFFFAOYSA-N

FDA UNII

76IC00YRVR

TAK-831 is under investigation in clinical trial NCT03214588 (Efficacy, Tolerability, and Pharmacokinetics of Multiple Doses of Oral TAK-831 in Adults With Friedreich Ataxia).

1 2D Structure

Luvadaxistat

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

6-[2-[4-(trifluoromethyl)phenyl]ethyl]-1,2-dihydropyridazine-3,4-dione

2.1.2 InChI

InChI=1S/C13H11F3N2O2/c14-13(15,16)9-4-1-8(2-5-9)3-6-10-7-11(19)12(20)18-17-10/h1-2,4-5,7H,3,6H2,(H,17,19)(H,18,20)

2.1.3 InChI Key

QBQMUMMSYHUDFM-UHFFFAOYSA-N

2.1.4 Canonical SMILES

C1=CC(=CC=C1CCC2=CC(=O)C(=O)NN2)C(F)(F)F

2.2 Other Identifiers

2.2.1 UNII

76IC00YRVR

2.3 Synonyms

2.3.1 Depositor-Supplied Synonyms

1. Luvadaxistat [usan]

2. Tak-831

3. 76ic00yrvr

4. Tak831

5. Chembl2338801

6. 4-hydroxy-6-{2-[4-(trifluoromethyl)phenyl]ethyl}pyridazin-3(2h)-one

7. 1425511-32-5

8. 4-hydroxy-6-(2-(4-(trifluoromethyl)phenyl)ethyl)pyridazin-3(2h)-one

9. 3(2h)-pyridazinone, 4-hydroxy-6-(2-(4-(trifluoromethyl)phenyl)ethyl)-

10. Luvadaxistat [inn]

11. Unii-76ic00yrvr

12. Luvadaxistat [who-dd]

13. Luvadaxistat; Tak-831

14. Schembl14719667

15. Bdbm50431085

16. Who 11254

17. Zinc95592350

18. At32834

19. Hy-109183

20. Cs-0116454

21. 4-hydroxy-6-(2-(4-(trifluoromethyl)phenyl)ethyl)-2,3-dihydropyridazin-3-one

2.4 Create Date

2013-03-21

3 Chemical and Physical Properties

Molecular Formula	C₁₃H₁₁F₃N₂O₂
Molecular Weight	284.23 g/mol
XLogP3	2.7
Hydrogen Bond Donor Count	2
Hydrogen Bond Acceptor Count	6
Rotatable Bond Count	3
Exact Mass	284.07726208 g/mol
Monoisotopic Mass	284.07726208 g/mol
Topological Polar Surface Area	58.2 Å²
Heavy Atom Count	20
Formal Charge	0
Complexity	424
Isotope Atom Count	0
Defined Atom Stereocenter Count	0
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1